zinc-dependent lipoprotein-associated phospholipase A2 inhibitor (ActivX)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namezinc-dependent lipoprotein-associated phospholipase A2 inhibitor (ActivX)
Drug Alias NameAX-10185AX-10479
ClassificationSmall molecules
Mechanisms of ActionLipoprotein-associated phospholipase A2 inhibitors
TargetsLipoprotein-associated phospholipase A2
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActivx Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActivx Biosciences Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A